Team of Wishbone veterans hang out a new shingle

Share this article:
Steven Michaelson
Steven Michaelson

Medical agency Wishbone was acquired years ago, but its leadership team is coming out of retirement with a new venture, dubbed Calcium.

The name is a nod to their old vehicle—bought by Rosetta in 2010 and absorbed into Publicis the following year—and an allusion to the brand building they say a small shop does better.

“It's the big agency experience without the bureaucracy,” says Steven Michaelson, who serves as the shop's CEO alongside his Wishbone partners Renee Mellas (president), Judy Capano (head of strategy) and Todd Neuhaus (creative director). Apart from a few full-time administrative, studio and editorial hands, they're it.

“Everyone in the industry is tired of being forced to work within the network model, where they have to leverage people of that caliber across five or ten brands with a lot of people working under them,” said Michaelson. “We're getting back to the thing that made Wishbone successful before we grew to 80 people and spent our time managing the employees rather than the business.”

The full-service shop, which is based in Midtown Manhattan, has an anchor account with Cardionet, and has just launched a campaign for the company's portfolio of ambulatory ECG monitoring systems. They're also doing project work on Avanir's pseudobulbar effect drug Nuedexta.

“Clients who want to grow with us will get the A Team on their account,” said Michaelson.

B. A. Baracus he's not, but he and his team built a substantial business on that premise once before.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.